Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122406462 | 12240646 | 2 | F | 20160613 | 20160406 | 20160904 | PER | US-ASTRAZENECA-2016SE26506 | ASTRAZENECA | 0.00 | M | Y | 95.30000 | KG | 20160904 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122406462 | 12240646 | 1 | PS | BYDUREON | EXENATIDE | 1 | Unknown | 22200 | 2 | MG | /wk | ||||||||
| 122406462 | 12240646 | 2 | SS | LISINOPRIL. | LISINOPRIL | 1 | Oral | 10.0MG UNKNOWN | U | 0 | 10 | MG | TABLET | ||||||
| 122406462 | 12240646 | 3 | SS | LISINOPRIL. | LISINOPRIL | 1 | Oral | 10.0MG UNKNOWN | U | 0 | 10 | MG | TABLET | ||||||
| 122406462 | 12240646 | 4 | SS | LISINOPRIL. | LISINOPRIL | 1 | Oral | 5.0MG UNKNOWN | U | 0 | 5 | MG | TABLET | ||||||
| 122406462 | 12240646 | 5 | SS | LISINOPRIL. | LISINOPRIL | 1 | Oral | 5.0MG UNKNOWN | U | 0 | 5 | MG | TABLET | ||||||
| 122406462 | 12240646 | 6 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 20.0MG UNKNOWN | U | U | 0 | 20 | MG | TABLET | |||||
| 122406462 | 12240646 | 7 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Unknown | GENERIC UNKNOWN | U | U | 0 | ||||||||
| 122406462 | 12240646 | 8 | SS | ONGLYZA | SAXAGLIPTIN HYDROCHLORIDE | 1 | Oral | 0 | TABLET | ||||||||||
| 122406462 | 12240646 | 9 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | 1000 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122406462 | 12240646 | 1 | Diabetes mellitus |
| 122406462 | 12240646 | 2 | Blood pressure abnormal |
| 122406462 | 12240646 | 3 | Renal disorder |
| 122406462 | 12240646 | 4 | Blood pressure abnormal |
| 122406462 | 12240646 | 5 | Renal disorder |
| 122406462 | 12240646 | 6 | Hyperlipidaemia |
| 122406462 | 12240646 | 7 | Hyperlipidaemia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122406462 | 12240646 | Red blood cell abnormality | |
| 122406462 | 12240646 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122406462 | 12240646 | 1 | 201407 | 0 | ||
| 122406462 | 12240646 | 2 | 2013 | 201510 | 0 | |
| 122406462 | 12240646 | 3 | 2013 | 201510 | 0 | |
| 122406462 | 12240646 | 4 | 201510 | 0 | ||
| 122406462 | 12240646 | 5 | 201510 | 0 | ||
| 122406462 | 12240646 | 6 | 2011 | 0 | ||
| 122406462 | 12240646 | 7 | 2011 | 0 | ||
| 122406462 | 12240646 | 8 | 2011 | 2014 | 0 |